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Th1 Cells Regulate Hematopoietic Progenitor
Cell Homeostasis by Production of Oncostatin M
-13, mediate allergic inflammatory disease. Recruitment
of myeloid cells to sites of inflammation reduces the
number of cells available for innate immune system re-
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The commitment to a T helper cell differentiated stateSouth San Francisco, California 94080
is determined by members of the signal transducer and
activator of transcription (STAT) family of proteins. Stat4
is expressed primarily in lymphoid and myeloid cellsSummary
and in mice is activated by IL-12 and the related cytokine
IL-23 (Yamamoto et al., 1994; Zhong et al., 1994; BaconRegulation of hematopoietic progenitor cell homeosta-
sis is crucial for maintenance of innate immunity and et al., 1995; Jacobson et al., 1995; Oppmann et al., 2000).
Stat4-deficient mice lack IL-12-stimulated responses,the ability of the body to respond to injury and infection.
In this report, we demonstrate that progenitor cell num- including the induction of IFN-, and have impaired de-
velopment of Th1 cells (Kaplan et al., 1996b; Thierfelderbers and cycling status in vivo are dramatically increased
in mice deficient in Stat6 and decreased in mice deficient et al., 1996). In contrast, Stat6 is ubiquitously expressed
and is primarily activated by IL-4 and IL-13 (Hou et al.,in Stat4, targeted mutations which also alter T helper
cell polarization. Experiments using mice that have T 1994; Lin et al., 1995; Quelle et al., 1995). In Stat6-defi-
cient mice, the ability of T cells to differentiate into nor-cell restricted transgenic expression of Stat4 or Stat6
or have been in vivo depleted of T cell subsets demon- mal Th2 cells is greatly decreased (Kaplan et al., 1996a;
Shimoda et al., 1996; Takeda et al., 1996). The lack ofstrate that CD4 T cells regulate progenitor cell activ-
ity. Injection of the Th1 cytokine Oncostatin M but Th cell subsets in vivo has allowed these mice to be
used as models for examining the roles of Th1 and Th2not other cytokines into Stat4-deficient mice recovers
progenitor cell activity to wild-type levels. Thus, T cells in diseases and other immunological responses in
vivo (Kaplan et al., 1998a, 1998b; Kuperman et al., 1998;helper cells actively regulate hematopoietic progeni-
tor cell homeostasis. Tarleton et al., 2000).
In this report, we demonstrate that deficiencies in
Stat4 and Stat6 also dramatically affect myeloid progen-Introduction
itor cell numbers and their cycling activity. In the ab-
sence of Stat4, progenitor cell numbers and cycling sta-Myeloid cells are integral components of the innate im-
mune system. They are often the first line of defense tus are decreased. Conversely, in the absence of Stat6,
following infection and injury. Some myeloid cells are progenitor cell numbers and cycling status are in-
also involved in recruiting and activating antigen-spe- creased. Expression of Stat4 restricted to T cells of
cific cells, components of the acquired immune system, Stat4-deficient mice, or of a constitutively active mutant
at sites of inflammation. T cells can amplify the inflam- of Stat6 restricted to T cells of Stat6-deficient mice,
matory response by additional myeloid recruitment. T returns the progenitor activity to normal. Depletion of
helper subsets regulate distinct types of inflammation CD4 cells in Stat6-deficient mice reduces progenitor
(reviewed in Abbas et al., 1996; Glimcher and Murphy, cell activity to normal or below normal levels while hav-
2000). Th1 cells, which predominantly secrete IFN- and ing no effect on Stat4-deficient mice. The phenotype in
LT, regulate cell-mediated immunity, which includes Stat4-deficient mice correlates with decreased secre-
the recruitment and activation of neutrophils and anti- tion of Oncostatin M (OSM) in Stat4-deficient Th1 cells,
gen-presenting cells (macrophages and monocytes). By and in vivo injection of OSM into Stat4-deficient mice
contrast, Th2 cells, which secrete IL-4, -5, -6, -10, and results in normal levels of hematopoietic progenitor cell
numbers and levels of cycling. Together, this data sug-
gests that T helper subsets actively regulate myeloid5 Correspondence: mkaplan2@iupui.edu (M.H.K.), hbroxmey@iupui.
edu (H.E.B.) progenitor cell homeostasis.
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Figure 2. Normal Levels of Splenic and Bone Marrow Myeloid Cells
in Stat4- and Stat6-Deficient Mice
Figure 1. Altered Homeostasis of Hematopoietic Progenitor Cells
(A) Balb/c wild-type and Stat6-deficient spleen and bone marrowin Stat4- and Stat6-Deficient Mice
were analyzed by flow cytometry for the levels of CD11b and Gr-1
Bone marrow (A) or spleen (B) cells were analyzed for hematopoietic cells. Numbers indicate the percentages of cells in each quadrant
progenitor cell numbers (top) and cycling status (bottom) from mice and are representative of triplicate analysis.
of the indicated genotype. Results are the average SEM of eleven (B) C57BL/6 wild-type and Stat4-deficient bone marrow were ana-
Balb/c, seven Stat4-deficient, or seven Stat6-deficient mice, all indi- lyzed by flow cytometry for the levels of CD11b and Gr-1 cells
vidually assessed from a total of two separate experiments. Aster- as above.
isks indicate significant difference from wild-type mice: **, p 
0.0025; *, p  0.03.
to control mice. The cycling status of Stat4-deficient
progenitor cells is also significantly decreased com-
pared to wild-type controls such that these cells areResults
in a slow or noncycling state (Figure 1A). In contrast,
absolute progenitor cell numbers from Stat6-deficientAltered Hematopoietic Progenitor Cell Homeostasis
in Stat4- and Stat6-Deficient Mice bone marrow are increased in number and have greatly
increased percentages of cycling cells (Figure 1A). InSince Stat4- and Stat6-deficient mice have dramatic
alterations in their in vivo T helper subset profile, we the spleen, the differences between wild-type and Stat4-
deficient cells are reduced, though there is still a trendwanted to determine whether these changes had any
affects on the pool of hematopoietic progenitor cells. To toward reduced numbers and cycling (Figure 1B). Stat6-
deficient cells, however, show significant increases intest this, we performed ex vivo hematopoietic progenitor
cell colony-forming assays on bone marrow and spleen absolute progenitor cell numbers and striking increases
in the percentages of cells that are cycling in spleencells from wild-type Balb/c and Stat4- or Stat6-deficient
mice on the Balb/c genetic background. Total cells from (Figure 1). These studies demonstrate that the absence
of Stat4 or Stat6 in vivo alters the homeostasis of hema-bone marrow and spleen are plated in the presence
of a cytokine cocktail that stimulates optimal colony topoietic progenitor cells in bone marrow and spleen.
To determine if the alterations in hematopoietic pro-formation from progenitor cells present in the organs.
This allows assessment of the absolute number of sub- genitor cell activity results in altered levels of mature
cells in these organs, we analyzed the levels of Gr-1andtypes of progenitor cells in vivo by differentiating the
progenitor cells to colonies in vitro. Pulse exposure of CD11b cells by flow cytometry. Figure 2A demonstrates
that similar levels of CD11b and CD11b/Gr-1 cells arecells with high specific activity 3 H-thymidine prior to
plating allows assessment of the proportion of progeni- observed in Balb/c wild-type and Stat6-deficient bone
marrow and spleen populations. There are also no sig-tor cells proliferating in vivo. Figure 1A demonstrates
that in the absence of Stat4, absolute numbers of granu- nificant differences observed between C57BL/6 wild-
type and Stat4-deficient bone marrow cells (Figure 2B).locyte-macrophage (CFU-GM), erythroid (BFU-E), and
multipotential (CFU-GEMM) progenitor cells present in These results suggest that despite the altered homeo-
stasis of progenitor cells in the spleen and bone marrowthe bone marrow are significantly decreased compared
Th1 Cells Regulate Hematopoiesis
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of Stat4- and Stat6-deficient mice, the homeostasis of
mature myeloid cells occurs normally in the absence of
Stat4 and Stat6.
Altered Hematopoietic Progenitor Cell Activity
in IL-4-, IL-12-, and IL-13-Deficient Mice
We next wanted to determine the mechanism of Stat4-
and Stat6-dependent hematopoietic progenitor cell
regulation. We first determined if mice lacking in the
cytokines that activate Stat4 and Stat6 have similar phe-
notypes in the progenitor cell populations. IL-12 has
been shown to be a myeloid progenitor cell growth factor,
though most of its positive effects on growth are ne-
gated by the simultaneous induction of IFN- secretion
that is a negative regulator of progenitor growth (Jacob-
sen et al., 1993; Eng et al., 1995). Similarly, IL-4 and IL-
13 have been shown to be positive factors (Broxmeyer
et al., 1988; Sonoda et al., 1990), a phenotype that appar-
ently conflicts with that observed in the Stat6-deficient
mice. To test this, we performed assays of progenitor
cell numbers and cycling status on mice deficient in
IL-12 p40, IL-4, or IL-13. The phenotype of IL-12 p40-
deficient mice was remarkably similar to that seen in
Stat4-deficient mice (Figure 3A). Numbers and cycling
of progenitors in the bone marrow were significantly
reduced from control values. This result suggests that
the phenotype observed in Stat4-deficient mice corre-
lates with the biological function of IL-12 p40, which
may include IL-12 and IL-23 activity, and not novel Stat4-
activating cytokines.
The phenotype of progenitor cells in the IL-4-deficient
mice, however, was completely dissimilar to the ob-
served phenotype of progenitor cells in the Stat6-defi-
Figure 3. Altered Homeostasis of Hematopoietic Progenitor Cellscient mice. In bone marrow, progenitor numbers and
in IL-4-, IL-12-, and IL-13-Deficient Micecycling were significantly decreased compared to con-
Bone marrow cells (A and B) and spleen cells (C) were analyzedtrol mice (Figure 3A), agreeing with previously published
for hematopoietic progenitor cell numbers (top) and cycling statusreports. To determine if IL-13 has an effect on hemato-
(bottom). Results are the average  SEM of three individually as-poietic progenitor cells in vivo, we next analyzed IL-13-
sessed C57BL/6, 129/Sv, Balb/c, IL-4-deficient, or IL-12-deficient
deficient mice. Importantly, because of the linkage of mice and five individually assessed IL-13-deficient mice. Asterisks
the IL-4 and IL-13 genes, IL-13-deficient mice also have indicate significant difference from wild-type mice in (A) and from
C57BL/6 mice in (B) and (C): **, p  0.005; *, p  0.05.decreased endogenous IL-4 production, leading to a
profound deficiency in Th2 activity (McKenzie et al.,
1998b; Guo et al., 2001). Because the IL-13-deficient
mice are on a mixed C57BL/6  129 genetic back- 2000). The Stat4 mRNA has also been observed in bone
ground, we examined progenitor activity in C57BL/6 and marrow and myeloid cell lines (Yamamoto et al., 1994).
129/Sv mice as controls. IL-13-deficient mice had signif- We performed immunoblot analysis of lymph node and
icantly increased progenitor numbers and cycling in the bone marrow cell extracts for the expression of Stat4
bone marrow (Figure 3B) and spleen (Figure 3C) com- and Stat6 (Figure 4A). As expected, Stat6 is expressed
pared to either wild-type background strain. Thus, an at equivalent levels in both tissues. However, while ex-
in vivo environment that lacks IL-13, has reduced IL-4, pression of Stat4 was detected in lymph node extracts,
and might have an increased Th1 environment produces it could not be detected in bone marrow extracts (Figure
a hematopoietic progenitor cell phenotype that is similar 4A). We also saw no expression of Stat4 in bone marrow
to the Stat6-deficient phenotype. cells enriched for the lineage-negative, ckit population
(data not shown). Thus, while IL-12 may have some
direct effects on colony-forming cells, the lack of de-T Helper Cells Regulate Hematopoietic Progenitor
Cell Activity tected expression of Stat4 suggests that these functions
must be independent of Stat4. These results suggestWe next wanted to test whether it was possible for
IL-4, IL-13, and IL-12 to be exerting Stat4- and Stat6- that Stat4 has indirect effects on the hematopoietic pro-
genitor cell populations, possibly through the ability todependent functions in progenitor populations. While
Stat6 is ubiquitously expressed (Hou et al., 1994; Quelle regulate T helper (Th) cell differentiation.
The reciprocal phenotypes of progenitor cell activityet al., 1995), constitutive Stat4 expression is restricted
to lymphoid tissues and can be induced in myeloid cells in Stat4- and Stat6-deficient mice are reminiscent of the
alterations in T helper cell subset development. It is(Yamamoto et al., 1994; Zhong et al., 1994; Frucht et al.,
Immunity
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Figure 4. T Cell Expression of Stat4 or Stat6
Recovers Normal Hematopoietic Progenitor
Cell Homeostasis on the Stat4- or Stat6-Defi-
cient Background
(A) Total cell extracts (100 g) from wild-type,
Stat4-deficient, or CD2:Stat4 lymph node and
bone marrow were analyzed by immunoblot
for Stat4 and Stat6 expression.
(B) CD4 cells from Stat4/, Stat4-deficient,
or CD2:Stat4 were cultured under Th1 pro-
moting conditions for 6 days. Cells were
washed and restimulated with anti-CD3.
Twenty-four hour supernatants were ana-
lyzed for IFN- levels by ELISA.
(C and D) Bone marrow (C) or spleen (D) cells
were analyzed for hematopoietic progenitor
cell numbers (top) and cycling status (bot-
tom). Results are the average SEM of three
individually assessed C57BL/6, Stat4-defi-
cient, or CD2:Stat4 mice.
(E) Bone marrow cells were analyzed for he-
matopoietic progenitor cell numbers in mice
with the wild-type, Stat6-deficient mice, or
CD2:Stat6VT genotype. Asterisks indicate
significant difference from wild-type mice: **,
p  0.005; *, p  0.05.
possible that reciprocal Th subsets are regulating hema- After 6 days in culture, cells were washed and left un-
stimulated or stimulated with anti-CD3. After 24 hr, su-topoietic progenitor cell homeostasis. To directly test
whether T cell-restricted expression of Stat4 was suffi- pernatants were recovered and tested for levels of IFN-
secretion. As reported, IFN- secretion is dramaticallycient to recover normal progenitor cell activity, we gen-
erated transgenic mice that express Stat4 under control reduced in the Stat4-deficient cultures (Figure 4B). Im-
portantly, transgenic expression of Stat4 recovers theof the CD2 locus control region. These transgenic mice
were backcrossed to C57BL/6 mice for two generations ability of CD2:Stat4 cells to become IFN--secreting Th1
cells (Figure 4B). We then repeated the analysis of hema-and to Stat4/ C57BL/6 for two generations to generate
Stat4-deficient transgene-positive mice (CD2:Stat4). Fig- topoietic progenitor cell characteristics in wild-type,
Stat4-deficient, and CD2:Stat4 mice, as performed inure 4A demonstrates the expression of transgenic Stat4
in lymph node cells of transgene-positive mice at levels Figure 1. As seen previously, Stat4 deficiency leads to
decreases in bone marrow and spleen progenitor num-somewhat less than that seen in wild-type mice. We
observed no expression of the transgenic Stat4 in bone bers even more dramatically than seen from animals
on the Balb/c genetic background (Figures 4C and 4Dmarrow supporting the specificity of expression of the
transgene. With purified cells and other tissues, we pri- compared to Figure 1). Cycling of progenitors in the
bone marrow was also dramatically reduced (Figure 4C).marily see expression of the transgene in T cells, with
low expression in B cells and no expression detected Importantly, T cell-specific expression of Stat4 in the
CD2:Stat4 mice was sufficient to restore all parametersin nonlymphoid cells. Since the transgenic mice were
on the C57BL/6 background, we performed the analysis to wild-type levels (Figures 4C and 4D).
To test the converse, whether T cell-specific expres-of these mice with wild-type and Stat4-deficient mice
on the C57BL/6 background. To demonstrate that the sion of Stat6 can restore increased progenitor activity to
normal, we generated mice that express a constitutivelytransgenic Stat4 is capable of recovering endogenous
Stat4 function, we differentiated purified CD4 T cells active form of Stat6 (termed Stat6VT) under control of
the CD2 LCR (Daniel et al., 2000). These mice will befrom wild-type, Stat4-deficient, and CD2:Stat4 mice.
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described in detail elsewhere. Transgene-positive mice Oncostatin M Stimulates Progenitor Activity
If T helper subsets are regulating hematopoietic progen-were mated to Stat6-deficient mice to generate Stat6VT-
expressing, Stat6-deficient mice (CD2:Stat6VT). While itor cell activity, it seems likely that this is due to the
Th1-specific secretion of a cytokine. To determine ifStat6-deficient mice have increased numbers of hema-
topoietic progenitors, expression of Stat6VT in the T cell Stat4 was required for the expression of a cytokine re-
quired for normal colony-forming cell activity, we per-compartment is sufficient to reduce progenitor numbers
to normal or below normal (Figure 4E). Thus, the expres- formed ribonuclease protection analysis of cytokine ex-
pression in wild-type and Stat4-deficient Th1 cultures.sion of Stat4 or Stat6 in T cells regulates colony-forming
cell activity in vivo. IL-3 and GM-CSF have been described as being se-
creted by both Th1 and Th2 subsets (Mosmann et al.,To continue to characterize the role of T helper cells
in regulation of hematopoietic progenitor cells, we hy- 1986). Expression of both of these cytokines was ob-
served in wild-type Th1 cells, and expression was notpothesized that depletion of CD4 cells in vivo would
alter the progenitor cell phenotypes observed in the affected by the absence of Stat4 (Figure 6A). We also
observed expression of M-CSF and IL-6 in wild-typeSTAT-deficient mice. In vivo depletion of CD4 cells
from Stat6-deficient mice should lead to a decrease or Th1 cells. Expression of M-CSF was reduced in the ab-
sence of Stat4 (Figure 6A). However, it is unlikely thatnormalization of hematopoietic progenitor cell activity
following the elimination of the Stat4-dependent popula- M-CSF is responsible for the phenotype, since it does
not have effects on all the colony-forming cells studiedtion responsible for the phenotype. To test this, Stat6-
deficient mice were injected intraperitoneally with PBS and since expression was also observed in Th2 cells
(data not shown). Other cytokines which are known toor 200 g anti-CD4 or anti-CD8 every 3 days for 9 days.
As a control, wild-type Balb/c mice were injected at the have an affect on many types of colony-forming cells,
including IL-11, LIF, G-CSF, SCF/SLF, and Flt3L, weresame times with PBS. Twenty-four hours after the last
injection, mice were sacrificed for analysis as in Figure not expressed in Th1 or Th2 cells (Figure 6A and data
not shown). Another cytokine, OSM, is known to affect1. FACS analysis demonstrated no significant differ-
ences in the splenic CD4 and CD8 populations of wild- hematopoietic progenitor cell activity and has recently
been described as preferentially expressed in humantype and Stat6-deficient mice. Percentages of splenic
CD4 cells in anti-CD4-treated Stat6-deficient mice Th1 cells (Rogge et al., 2000). To determine if OSM was
also expressed in murine Th1 cells and if that expressionwere greater than 97% depleted, though importantly the
percentage of Lin-Sca-1c-kit cells in the bone marrow was Stat4 dependent, we differentiated CD4 T cells
under Th1- or Th2-promoting conditions. After 6 dayswas not affected (data not shown). Similarly, anti-CD8-
treated Stat6-deficient mice showed 98% depletion of in culture, cells were washed and restimulated with anti-
CD3. Supernatants were collected after 72 hr and testedsplenic CD8 cells. These T cell-depleted mice were
then used for hematopoietic progenitor cell analysis as by ELISA for the level of OSM. OSM could be detected
in wild-type Th1 cells. The levels of OSM detected indescribed above. In the bone marrow, CD4 cell deple-
tion decreased progenitor cell numbers to levels indis- supernatants of Stat4-deficient cultures were greatly re-
duced compared to wild-type cells (Figure 6B). Minimaltinguishable from wild-type cells (Figure 5A, top). Treat-
ment with anti-CD8 did not have as dramatic an effect, OSM secretion was detected in wild-type Th2 cultures
though considerably higher levels were detected inand only CFU-GM were significantly below numbers of
colonies in PBS-treated Stat6-deficient mice. Cycling in Stat6-deficient Th2 cultures (Figure 6B). Stimulation of
primary CD4 cells with anti-CD3 produced slightlythe bone marrow was reduced below wild-type levels
in anti-CD4-treated Stat6-deficient mice and was unaf- lower levels of OSM from Stat4-deficient cells than from
wild-type cells at several time points (Figure 6C). Tofected by treatment with anti-CD8 (Figure 5A, bottom).
In the spleen, the results were even more dramatic. Anti- determine if regulation of OSM in Th subsets was tran-
scriptional, we differentiated CD4 Th subsets as aboveCD4 treatment of Stat6-deficient mice reduced hemato-
poietic progenitor numbers to wild-type or below wild- and isolated total RNA after 24 hr of stimulation. OSM
expression was inducible by anti-CD3 in Th1 but nottype levels (Figure 5B, top). Treatment with anti-CD8
increased progenitor numbers above that seen in PBS- Th2 cultures (Figure 6D), supporting the ELISA data and
agreeing with Rogge et al. (2000). In contrast to thattreated Stat6-deficient mice. Strikingly, anti-CD4 treat-
ment of Stat6-deficient mice completely abolished the report, however, we did not observe IL-12 (data not
shown) or IL-12  IL-18 inducible OSM expression inlevels of cycling cells, while anti-CD8 treatment had no
effect (Figure 5B, bottom). To demonstrate that CD4 murine wild-type Th1 cells (Figure 6D). Stat6-deficient
Th2 cultures had increased expression of OSM com-cell depletion was only affecting a positive and not a
negative factor, we also performed CD4 depletions on pared to wild-type Th2 cells. In contrast to the ELISA
results, however, OSM was still inducible by anti-CD3wild-type and Stat4-deficient mice. As in the Stat6-defi-
cient mice, CD4 depletion in wild-type mice also re- in Stat4-deficient Th1 cultures. These results suggest
that OSM production may be controlled both transcrip-duced both progenitor numbers and cycling in the bone
marrow (Figure 5C). In contrast, CD4 depletion of Stat4- tionally, as observed between Th1 and Th2 cells, and by
Stat4-regulated processes that may enhance translationdeficient mice had only minimal and statistically insignif-
icant effects on progenitor numbers or cycling in the or secretion. Thus, OSM was considered a candidate
cytokine that might be responsible for the reduced he-bone marrow (Figure 5C). Together these data suggest
that Th cells positively regulate hematopoietic progeni- matopoietic progenitor cell activity in Stat4-deficient
mice.tor cell activity and alterations in the Th subset profile
within mice can dramatically affect progenitor numbers To test whether replacement of OSM would correct
the phenotype of Stat4-deficient mice, we injected OSMand cycling status in the spleen and bone marrow.
Immunity
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Figure 5. Depletion of CD4 Cells In Vivo Al-
ters Hematopoietic Progenitor Cell Homeo-
stasis in Wild-Type and Stat6-Deficient but
Not Stat4-Deficient Mice
(A and B) Bone marrow (A) or spleen (B) cells
were analyzed for hematopoietic progenitor
cell numbers (top) and cycling status (bot-
tom). Results are the average  SEM of six
individually assessed Balb/c, Stat6-deficient,
anti-CD4-treated Stat6-deficient, or anti-
CD8-treated Stat6-deficient mice from a total
of two separate experiments.
(C) Bone marrow cells were analyzed for he-
matopoietic progenitor cell numbers (top)
and cycling status (bottom) of Balb/c or
Stat4-deficient mice injected with PBS or
anti-CD4 as indicated. Results are the
average  SEM of 3–4 individually assessed
mice per group. Asterisks indicate significant
difference from Stat6-deficient mice ([A] and
[B]) or wild-type mice (C): **, p 0.005; *, p
0.05.
or PBS as a control into wild-type and Stat4-deficient ingly, OSM increased Stat4-deficient progenitor num-
bers to levels that were indistinguishable from wild-typemice. As an additional control for the specificity of OSM
function, we also injected IL-6, which belongs to the levels (Figure 6E). OSM also increased the cycling status
of wild-type and Stat4-deficient progenitor cells to levelssame cytokine family as OSM and has been shown to
be involved in the regulation of hematopoietic colony- that were significantly increased over PBS-injected wild-
type mice (Figure 6E). Thus, these data suggest thatforming cells (Bernad et al., 1994). IL-6R and OSMR also
share the gp130 component of their receptors (Kamiya one potential regulatory mechanism of hematopoietic
progenitor cell homeostasis by T helper cells is throughet al., 1999; Tanaka et al., 1999). Cytokines were injected
twice a day for 2 days, and mice were sacrificed for Th1-specific secretion of OSM.
analysis of bone marrow progenitor activity 12 hr after
the final injection. Analysis demonstrated that Stat4- Discussion
deficient cells had decreased hematopoietic progenitor
numbers and cycling (Figure 6E), as seen previously These results describe a new role for T helper cells:
regulating hematopoietic progenitor cell homeostasis.(Figures 1 and 4). Injection of IL-6 had no significant
effect on either progenitor numbers or cycling status in Stat4-deficient mice, which have impaired development
of Th1 cells, have diminished levels of hematopoieticwild-type or Stat4-deficient mice (Figure 6E) in this
assay. OSM injection resulted in modest though insignif- cell numbers and cycling. In contrast, Stat6-deficient
mice have increased progenitor numbers and cycling,icant increases in wild-type progenitor numbers. Strik-
Th1 Cells Regulate Hematopoiesis
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Figure 6. Oncostatin M Administration In
Vivo Rescues the Activity of Stat4-Deficient
Hematopoietic Progenitor Cells
(A) Wild-type or Stat4-deficient CD4 T cells
were incubated for 6 days under Th1 culture
conditions and left unstimulated or stimu-
lated with 2 g/ml plate bound anti-CD3 for
24 hr. RNA was isolated and used for ribo-
nuclease protection analysis. The identity of
the probe bands and protected bands is indi-
cated.
(B) Th1 or Th2 cultures of the indicated geno-
types were stimulated for 72 hr with plate-
bound anti-CD3. Supernatants were har-
vested for analysis using an OSM-specific
ELISA.
(C) Primary CD4 T cells were stimulated with
anti-CD3. At the indicated time points, super-
natants were removed and analyzed for OSM
levels by ELISA.
(D) RNA was isolated from Th1 or Th2 cultures
of the indicated genotype left unstimulated
or stimulated with 2 g/ml anti-CD3 or 2 ng/
ml IL-12  25 ng/ml IL-18 as indicated for 24
hr. Following transfer to a nylon membrane,
RNA was hybridized with labeled Oncostatin
M cDNA. Membranes were stripped and re-
probed for TCR expression as a control.
(E) Wild-type or Stat4-deficient mice were in-
jected with PBS, IL-6, or OSM (2 g) twice a
day for 2 days. Twelve hours after the last
injection, bone marrow cells were harvested
for analysis of colony-forming cell numbers
(top) and colony-forming cell cycling status
(bottom) as described above. Results are the
average of three wild-type and four Stat4-
deficient individually assessed mice in each
group and are representative of two separate
experiments. Asterisks indicate significant
difference from wild-type mice: **, p  0.005;
*, p  0.05.
with increased Th1 activity and impaired Th2 activity wild-type levels of progenitor numbers and cycling in
Stat4-deficient mice. These data are consistent with ain vivo. We hypothesized that T helper cells may be
important for regulating hematopoietic progenitor cell hypothesis wherein T helper cells are actively involved
in regulating hematopoietic progenitor cell homeostasis.activity in vivo. To test this, we used mice that had T
cell-specific transgenic expression of Stat4 on a Stat4- There are several lines of evidence supporting our
hypothesis that the role of Stat4 and Stat6 in regulationdeficient background or a constitutively active Stat6 on
a Stat6-deficient background. These mice had normal of hematopoietic progenitor cells is indirect, affecting
Th cell polarization. First, gene-deficient mice lacking inlevels of progenitor activity. Furthermore, in vivo deple-
tion of CD4 cells but not CD8 cells reduced the level cytokines involved in T helper differentiation had similar
defects. IL-12 p40-deficient mice had a similar pheno-of progenitor activity in Stat6-deficient mice to normal
or below normal levels. In an examination of cytokines type to Stat4-deficient mice. IL-13-deficient mice, which
also have reduced IL-4 production and presumably anthat might be responsible for this phenotype, we ob-
served Oncostatin M secretion reduced in Stat4-defi- increased Th1 environment, had a phenotype similar to
the Stat6-deficient mice. Second, we found no expres-cient Th1 cultures. Moreover, the diminished in vivo Th1
responses of Stat4-deficient mice make it likely that the sion of Stat4 in primary bone marrow or purified lineage-
negative, c-kit cells (Figure 4). If these cells do notlevels of OSM in vivo would be lower and compara-
ble to Th2 levels. Injection of OSM in vivo recovered express detectable Stat4, it is unlikely that they are di-
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rectly affected by Stat4 deficiency. Third, T cell-specific to Stat6-deficient mice. Thus, hematopoietic progenitor
transgenic expression of Stat4 or Stat6 recovers pro- cell function is an interesting example of a response
genitor cell function. The transgene that directs expres- where cytokine deficiency and STAT deficiency yield
sion of Stat4 and Stat6 is based on the CD2 locus control opposite phenotypes.
region (Zhumabekov et al., 1995). In addition to T cells, Murine oncostatin M was first described as an IL-3-
CD2 can be expressed at low levels on B cells and NK inducible gene (Yoshimura et al., 1996). It has since been
cells but has not been detected on nonlymphoid cells. shown to have pleiotropic functions on many cell types,
We also did not detect expression of the transgenic including hematopoietic cells (Malik et al., 1995; Clegg
Stat4 in bone marrow cells or cells of nonlymphoid tis- et al., 1996; Kamiya et al., 1999; Kinoshita et al., 1999;
sues (Figure 4 and data not shown). Fourth, in vivo deple- Wallace et al., 1999; Boileau et al., 2000). OSM has been
tion of CD4 cells eliminates the hyperactivity of hema- specifically linked to the myeloproliferative disorder as-
topoietic progenitor cells in Stat6-deficient mice and sociated with TEL/JAK2-transduced bone marrow
reduces progenitors in wild-type mice (Figure 5). Finally, (Schwaller et al., 2000). Th1 cells may not be the only
the injection of a Th1 cytokine into Stat4-deficient mice source of in vivo OSM production, since activated T
increases hematopoietic progenitor cell activity to wild- cells and macrophages also secrete OSM (Wallace et
type levels (Figure 6). Together, these data support a al., 1999). While OSM injection was sufficient to increase
model in which Th1 cells regulate hematopoietic pro- levels of hematopoietic progenitor cell numbers and cy-
genitor cell numbers and cycling status. cling to wild-type levels, it does not exclude the role
It is likely that progenitor cell activity is regulated by of other cytokines in this process and may be acting
many cell types other than Th cells. In addition to the indirectly, since OSM had little effect by itself in vitro in
positive function of Th1 cells on progenitor cells we have the absence of other growth factors. Importantly, OSM
described, it is possible that Th2 cells might also exert a appears to be the only candidate cytokine with an ex-
negative effect on hematopoietic progenitor cell activity. pression pattern that correlates with T helper cell regula-
However, we think a regulatory role for Th2 cells is un- tion of hematopoietic progenitor cells.
likely. First, OSM was able to recover progenitor cell We have demonstrated that OSM is one potential
activity in Stat4-deficient mice in vivo in the absence of component of T cell-hematopoietic progenitor cell com-
manipulation of the existing in vivo Th2 populations. munication that increases progenitor cell activity. It may
Additionally, IFN--deficient mice, which also develop be that stimulation of Th1 cells at sites of inflammation
strong Th2 responses, have increased numbers of col- leads to OSM secretion. Since so many cytokines have
ony-forming cells (Murray et al., 1998), suggesting that effects on progenitor cell activity in vivo, and those cyto-
an active Th2 population by itself does not result in kines can be secreted by many cells, including T cells,
decreased progenitor cell activity. In vivo depletion of myeloid cells, stromal cells, and endothelial cells, an
CD4 cells in Stat4-deficient mice did not increase pro- understanding of how the milieu regulates progenitor
genitor numbers or cycling, suggesting that there is not activity is not yet apparent. It is also intriguing that ma-
a Th suppressor factor in these mice. Furthermore, Th2 ture CD11b or Gr-1 populations are not dramatically
cytokines are not known to have functions that directly altered by the changes in the progenitor compartment
suppress progenitor activity. IL-4 is a growth factor, as of either Stat4- or Stat6-deficient mice. It is likely that
demonstrated both in gene-deficient mice (Figure 3) and the progenitor and mature cell “compartments” have
in vivo injections (data not shown). While IL-13-deficient separate homeostatic controls. However, we hypothe-
mice have increased progenitor numbers, IL-13 had size that under immunological stress, when granulo-
positive effects when injected in vivo and did not have cytes and macrophages are recruited to sites of inflam-
any effects on progenitor colony formation in in vitro mation, the Stat4-deficient mice would be less capable
assays of four different strains of mice (data not shown). of repopulating mature myeloid cells in various organs.
Thus, a factor in Th1 cells is responsible for the mainte-
Indeed, we have observed that 1 week after immuniza-
nance of hematopoietic progenitor cell homeostasis.
tion Stat4-deficient mice have only 50% of the wild-type
The differences in the progenitor cell phenotypes be-
level of mature granulocytes present in the bone marrowtween the IL-4- and Stat6-deficient mice can be ex-
(data not shown). Thus, this provides another level ofplained in several ways. IL-4 clearly functions as a
control that Th1 and Th2 cells can respectively perpetu-growth factor for hematopoietic progenitors both in vitro
ate and inhibit inflammatory responses. The role of Th(Broxmeyer et al., 1988) and in vivo (Figure 3 and data
cells in regulating this process will be the focus of ongo-not shown). Some IL-4-induced growth affects, as well
ing investigation.as protection from apoptosis, may signal through mole-
This report describes a regulatory role for T helpercules distinct from Stat6, including IRS proteins (Nelms
cells in hematopoietic progenitor cell homeostasis. Weet al., 1999). In IL-4-deficient mice, any IL-4-activated
propose that this regulation is critical for the innate im-pathways would be absent, producing the phenotype
mune system to maintain its ability to effectively respondobserved in vivo. In contrast, the Stat6-deficient mice
to infection and initiate wound repair.lack particular IL-4-stimulated functions, including Th2
generation. The positive and Stat6-independent effects
Experimental Proceduresof IL-4 on the progenitor populations may still be acti-
vated in Stat6-deficient mice, wherein increased Th1
Mice
activity would also increase progenitor activity. Gene Generation of Stat4- and Stat6-deficient mice has been described
targeting of IL-13 also decreases IL-4 levels (McKenzie (Kaplan et al., 1996a, 1996b), and mice were backcrossed ten gener-
et al., 1998b; Guo et al., 2001), and this composite defect ations to the Balb/c or eight generations to the C57BL/6 genetic
background. The transgenic vector was generated by cloning theappears to result in a progenitor phenotype more similar
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human Stat4 cDNA or the Stat6VT cDNA into the CD2 locus control CD3 as noted. RNA was isolated 24 hr following stimulation and
used for an RNase protection assay using the probe template mCK-4region (Zhumabekov et al., 1995). Stat4 and Stat6VT transgenic mice
were generated by the IU transgenic facility (on a pure C3H genetic (BD Pharmingen). OSM levels in supernatants were determined
by ELISA using specific polyclonal antibodies (R&D Systems, Minne-background) and backcrossed two generations to C57BL/6 mice
and two generations to Stat4/ C57BL/6 mice or three generations apolis, MN) and recombinant OSM as the standard. Oncostatin M
expression was detected by Northern analysis as described (Zhangto the Balb/c Stat6/ mice, respectively. IL-4-deficient mice on the
Balb/c genetic background were purchased from Jackson Labora- et al., 2000).
tories (Bar Harbor, Maine). IL-12 p40-deficient mice were kindly
provided by Bruce Blazar. Generation of IL-13-deficient mice on a In Vivo Cytokine Injections
mixed C57BL/6  129 background has been previously described Oncostatin M (R&D Systems), IL-6 (Peprotech, Rocky Hill, NJ), or
(McKenzie et al., 1998a, 1998b). Control (wild-type) mice were pur- PBS was injected intraperitoneally twice daily (2g/dose) for 2 days.
chased from Jackson laboratories or Harlan Bioproducts (Indianap- Mice were sacrificed 12 hr after the final injection, and colony-
olis, IN). forming cell numbers and cycling status were analyzed as above.
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